Lumretuzumab

From WikiMD's Wellness Encyclopedia

Lumretuzumab is a monoclonal antibody designed for the treatment of cancer. This drug was developed by Roche.

History[edit | edit source]

Lumretuzumab was part of a collaboration between Roche and Genmab, a Danish biotechnology company. The drug was designed to target and bind to the HER3 (human epidermal growth factor receptor 3) protein, which is often overexpressed in certain types of cancer.

Clinical trials[edit | edit source]

In 2015, Roche initiated a phase I clinical trial for lumretuzumab. The trial was designed to evaluate the safety, tolerability, and efficacy of the drug in patients with advanced solid tumors. However, the results of the trial were not as promising as hoped, and Roche decided to discontinue the development of lumretuzumab in 2017.

Mechanism of action[edit | edit source]

Lumretuzumab works by binding to the HER3 protein on the surface of cancer cells. This binding inhibits the ability of the HER3 protein to send signals that promote cell growth and survival, thereby slowing or stopping the growth of the cancer.

See also[edit | edit source]

Lumretuzumab Resources
Wikipedia
WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD